Several previous studies have confirmed the function of CD25 blockade in depleting FoxP3+ Tregs in the tumor microenvironment, which activated FcγRs capable of inducing antibody dependent cellular cytotoxicity [8, 30, 31]. This evidence concerns the gene FOXP3 and neoplasm.